spacer
home > ebr > Winter 2019
PUBLICATIONS

European Biopharmaceutical Review

ebr
Winter 2019

   
Text
PDF
EBR’s Editor, Dr Deborah O’Neil, details all the innovations touched upon in this issue and how some can enhance cancer treatment.
 
view
download pdf
BioDiscovery
Biobanks and the Rise of Precision Medicines

Unlocking the Power of Data

Timo Kanninen at BC Platforms expresses the urgency surrounding data sharing, arguing that researchers need access to unique datasets if they wish to progress in personalised healthcare.
 
view
download pdf
Batch Releases and Brexit

The Impact of Brexit on the Pharma Industry

As Brexit negotiations become more pressing and the deadline continues to loom, ‘red lines’ navigation and plans for a ‘no-deal’ scenario must be established urgently. Lynne Byers at NSF International offers guidance on the potential challenges.
 
view
download pdf
bullet
Regional Focus: Scandinavia
Biopharma Investments in Scandinavia

Challenges for Small Businesses in the Global Pharma Market

The pharma industry has been forced to adapt over the years, going from a field deemed ‘safe’ and recession-proof to one of a constantly evolving and accelerating trajectory. Stephen McNeeney PhD at Potter Clarkson demonstrates how ever-increasing demands are moulding the industry.
 
view
download pdf
Scandinavia: What is in a Name?

Spot the Difference

Defining Scandinavia is a bigger question than most would realise. Tórben Thers Nørgaard at PharmaLex Nordics delves into the regional differences in compliance and packaging to highlight where gaps in expertise exist.
 
view
download pdf
Engineering Biopharmaceuticals to Address Intractable Diseases

Biopharmaceuticals for the Brain

Stephen James PhD, Erik Nordling PhD, and Stefan Svensson Gelius PhD at Sobi expand on how accomplishing therapeutically meaningful levels of biopharmaceuticals can be difficult to accomplish and why companies should consider exploring biological engineering to ease the process.
 
view
download pdf
bullet
DEVELOPMENT AND PRODUCTION
Drug Development Forecasts

Forecasting Development Stages to Stay Ahead of Compounds

Jamie Blackport and Chris Watson at Mirador Analytics recommend epidemiology-based forecasting to provide the best possible compound current value analysis available.
 
view
download pdf
bullet
RESEARCH AND DEVELOPMENT
Encapsulation and Microfluidics

Channelling the Future of Liposome Generation

Damiano Rossi at Dolomite Microfluidics and Anna Blakney at Imperial College review drug encapsulation, a drug delivery method that has signficantly increased in usage given the protection they can offer enclosed molecules.
 
view
download pdf
Drug Delivery to the Lungs

Thinking Throats with Anatomical Throat Models

The inhalation industry has largely welcomed anatomical throat models over the last few years. Samantha Holmes and Alex Slowey at 3M assess their utilisation, particularly in regard to in vivo testing.
 
view
download pdf
bullet
Analytical Tools
Computed Tomography Imaging

The Advent of Nanoparticle Contrast Agents

New methods, namely using nanoparticle and targeted contrast agents, are paving the way for better treatment efficiency and personalised treatment plans in the cancer arena, claims Dr Hannah Prebble at MARS Bioimaging.
 
view
download pdf
bullet
Innovations in Oncology
Minimal Residual Disease Assessment in Blood Cancers

Monitoring Malignancies Through Assay Development

Although progression in the drug development arena has improved prospects for blood cancers, companies should still consider assay-based methods to detect residual disease to ultimately improve patient care, suggests Ilan Kirsch at Adaptive Biotechnologies.
 
view
download pdf
bullet
Vaccines
The War Against Microbes

Vaccine Victories Against Microbial Resistance

Dr Donald F Gerson, Jonas Elliott Gerson, Allison Turner, and Dr Gail Meadows at PnuVax address the pressing issue that is antibiotic resistance, explaining that, though humans are definitely winning the battle, difficult organisms remain which are proving arduous to combat.
 
view
download pdf
Electron Beam- Sterilised Vaccines

Exploring Amino Acid-Based and Stable Spray-Dried Vaccines

Developing therapeutic biologics is no easy feat, as formulation issues act as a significant cause for drug development delays. The team at LEUKOCARE advise how best to approach the matter.
 
view
download pdf
Stopping the Spread of Infectious Diseases

The Value of Vaccines

Incidents of Lyme disease have rapidly increased over the last few decades, making it, globally, a significant risk. Thomas Lingelbach at Valneva presents the case for a vaccine against the illness.
 
view
download pdf
bullet
Drug Repurposing/Repositioning
Q&A: New Targeted Treatments

Embracing a New Lease of Life

Genea Biocells’Alex Kiselyov discusses with EBR the myriad advantages that are associated with drug repurposing, particularly in the realm of molecular biophysics and targets.
 
view
download pdf
Drug Repurposing for Infectious Diseases

Fighting the Damocles Sword of Infectious Diseases Through Drug Repurposing

Antimicrobial resistance poses a major challenge for the treatment of infectious diseases today. Andrés Pizzorno PhD at Signia Therapeutics explores how to address this from a drug repurposing perspective.
 
view
download pdf
bullet
Compliance and Regulation
Ethical Considerations in Human Biospecimens

Consent and Biospecimen Collection in Human Research

Informed consent is one of many ethical considerations that must be made when handling human research subjects. Tony Brown PhD and Kelly Sapsford at BioIVT lend their expertise on what factors to be aware of to meet regulations.
 
view
download pdf
Simplifying Regulatory Requirements

Compliance Complexity in the Data Management Landscape

Regulatory compliance may benefit from the adoption of a more holistic approach. Romauld Braun at AMPLEXOR is encouraging life sciences companies to review how they manage data in a time of increasing regulatory complexity.
 
view
download pdf
bullet
In Brief
In Brief

Gates and Doors

At the turn of the year, EBR’s Industry Advisor, Emile Bellott, reflects upon the progress made across biopharmaceutical sciences.
 
view
download pdf
   
spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July, and October

News and Press Releases

Signant Health Appoints Todd Everhart as Clinical Vice President to Accelerate Intelligent eCOA and Predictive Data Analytics in Medical Clinical Research

PHILADELPHIA, PA – August 20, 2019: Signant Health, formerly CRF Health and Bracket, has appointed Anthony Todd Everhart, MD, FACP to the Signant Health Science and Medicine Team as Clinical Vice President, Internal Medicine, reporting to the Chief Medical Officer, Dr. David Daniel.
More info >>

White Papers

Pharmaceuticals and Healthcare Products

Turkish Cargo

Pharmaceuticals are requiring safe and reliable transportation for being highly temperature sensitive products. Thosepharmaceuticals are; diagnostics, vaccines drugs, sera, plasma, protein clinical trials, biotechnological material, pills and all kind of medicines. Turkish Cargo transports all kind of pharmaceuticals, and has been carrying out its operations of transporting and storing drugs and temperature-sensitive medical supplies successfully and with the experience of 80 years; since 1936.
More info >>

Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement